NewLink Genetics Corp (NASDAQ:NLNK)

43.08
Delayed Data
As of Feb 27
 +0.95 / +2.25%
Today’s Change
17.32
Today|||52-Week Range
50.46
+8.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-18.1M-23.3M-31.2M--
 
 
 
 
Depreciation687.0K788.0K891.0K--
 
 
 
 
Total Other Cash Flow2.5M3.2M4.4M--
 
 
 
 
Funds From Operations-14.9M-19.3M-25.9M--
 
 
 
 
Funds From/For Other Operating Expenses-1.9M1.2M-104.0K--
 
 
 
 
Net Cash Flow - Operating Activities-12.9M-20.5M-25.8M--
 
 
 
 
 
InvestingIncrease In Investments-2.5M-2.0M-249.0K--
 
 
 
 
Decrease In Investments2.3M3.0M1.5M--
 
 
 
 
Capital Expenditures-281.0K-1.3M-1.4M--
 
 
 
 
Fixed Asset Disposal0.0050.0K0.00--
 
 
Net Cash Flow Investing-502.0K-277.0K-141.0K--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings13.0K456.0K0.00--
 
 
 
Long Term Debt Reduction-218.0K-229.0K-215.0K--
 
 
 
 
Net Proceeds Stock Sale42.6M1.3M67.2M--
 
 
 
 
Common Preferred Redeemed---4.0K0.00--
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing42.4M1.5M67.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash28.9M-19.2M41.0M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account